Ingevity (NGVT) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $1.63
- Estimate
- $1.59
- Surprise
- +2.7%
- Score at report (before → after)
- 5.0 → 4.8/10
Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.
How the report landed
Ingevity (NGVT) beat the $1.59 estimate with adjusted EPS of $1.63 — a modest 2.7% upside surprise. TrendMatrix's engine moved from Hold (5.0/10) to Sell at 4.8/10 after the report — the engine's score fell despite the beat.
Coverage in the report window
- Ingevity Q3 2026 Earnings Call Transcript — benzinga, 2026-11-05
- Ingevity Corporation Reports Q3 2026 Financial Results — fiscal.ai, 2026-11-04
- Ingevity Raises FY2026 Adj EPS Guidance from $5.00-$5.45 to $5.25-$5.45 vs $5.36 Est; Narrows FY2026 Sales Guidance from — benzinga, 2026-11-04
Where TrendMatrix's rating stands now
TrendMatrix currently rates NGVT Sell at 4.8/10.
3 of the last 4 quarters beat the estimate; this quarter's +2.7% surprise compares with a +17.2% four-quarter average. Next scheduled report: 2027-02-24.
What supports the rating
- Strong earnings beat streak (3/4)
- Attractive valuation
What argues against it
- Sector modifier (Basic Materials): -0.1
- Leverage penalty (D/E 26.4): -1.5
- Weak overall score: 4.8/10
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $61.82
- Price target
- $75.65
- Stop
- $59.01
- Upside to target
- +22.4%
- Reward-to-risk
- 2.3:1
The stock trades at 91.0× trailing but 10.6× forward earnings — consensus estimates already build in a substantial earnings recovery.
Risk check: RSI 30 — a level conventionally read as oversold.
Model outputs from TrendMatrix’s engine as of 2026-11-06 — shown for context, not personalized investment advice.
NGVT at TrendMatrix's latest read
Materials producers report against the commodity cycle — realized-price capture and volume, not the EPS line, are the tells in a quarter like this.
- Industry
- Specialty Chemicals
- Market cap
- $2.19B
- P/E (fwd)
- 10.6
- P/E (ttm)
- 91.0
- 52-week range
- $45.85–$79.29
- Off 52-week high
- 22.0%
- RSI (14)
- 30
- Volume vs avg
- 0.29×
- Score today
- 4.8/10